Intelligent Bio sees 48% Q2 revenue growth YoY, H1 revenue tops $2M

INTELLIGENT BIO SOLUTIONS INC.

2026-Q2 EPS reported -$6.27 revenue$2,008,571

Fiscal Q2 2026 revenue expected up ~48% YoY; readers more than double (+104% YoY).
H1 2026 total revenue ~$2.01M (+36% YoY); cartridge sales +38%, readers +50%.
CEO cites expanding installed base as foundation for recurring cartridge revenue.
Company expects to file 10-Q for Q2 ended Dec 31, 2025 during week of Feb 9, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.